
During the Health System Executive Summit, Candy Tsourounis, PharmD, and Elise Wozniak, PharmD got candid about the barriers and financial risk surrounding this innovative therapy.
New indication: Long-term, twice-daily treatment of bronchospasm associated with COPD






